Selank Dosing Protocol: Anxiolytic Research Guide

Also known as: TP-7

cognitive

Research Reference Only

This information is for educational purposes only. Selank is not FDA approved for human use. The protocols listed are summaries of published research studies and do not constitute medical advice. Always consult a licensed healthcare provider.

Overview

Selank is a synthetic peptide derived from tuftsin. It has been studied for its potential anxiolytic and nootropic effects, particularly in stress and anxiety models.

Mechanisms of Action

Modulates enkephalin system

Influences GABA receptors

Anti-anxiety effects

Immunomodulatory properties

Research Protocols

The following protocols are summaries of published research studies. They are presented for educational purposes only and do not constitute medical advice.

Protocol Name	Source	Dose	Frequency	Duration	Route	Evidence	Link
Anxiety Study	clinical trial	0.15% nasal spray	3x daily	14 days	Intranasal	human

Important Warnings

Safety Considerations

Prescription drug in Russia
Anxiolytic effects documented